GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 77 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $14,436,000 | +39.9% | 1,179,391 | +34.9% | 0.00% | 0.0% |
| Q3 2016 | $10,316,000 | +65.3% | 874,241 | +21.9% | 0.00% | +100.0% |
| Q2 2016 | $6,240,000 | +62.0% | 717,276 | -1.9% | 0.00% | 0.0% |
| Q1 2016 | $3,852,000 | -32.5% | 730,923 | -0.6% | 0.00% | 0.0% |
| Q4 2015 | $5,704,000 | +1.3% | 735,033 | +2.7% | 0.00% | 0.0% |
| Q3 2015 | $5,631,000 | -3.1% | 715,555 | +11.5% | 0.00% | 0.0% |
| Q2 2015 | $5,813,000 | -29.0% | 641,632 | +1.7% | 0.00% | 0.0% |
| Q1 2015 | $8,188,000 | +17.6% | 630,838 | +23.3% | 0.00% | 0.0% |
| Q4 2014 | $6,964,000 | +69.8% | 511,701 | +11.9% | 0.00% | 0.0% |
| Q3 2014 | $4,102,000 | -38.7% | 457,297 | -7.5% | 0.00% | 0.0% |
| Q2 2014 | $6,692,000 | +62.9% | 494,615 | +19.7% | 0.00% | 0.0% |
| Q1 2014 | $4,109,000 | -24.6% | 413,359 | +0.8% | 0.00% | 0.0% |
| Q4 2013 | $5,449,000 | +3.3% | 410,031 | -5.6% | 0.00% | 0.0% |
| Q3 2013 | $5,274,000 | +61.3% | 434,438 | +37.5% | 0.00% | 0.0% |
| Q2 2013 | $3,269,000 | – | 315,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 2,730,000 | $11,384,000 | 2.77% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,017,483 | $20,923,000 | 1.28% |
| Ghost Tree Capital, LLC | 500,000 | $2,085,000 | 0.49% |
| Bellevue Group AG | 773,677 | $3,226,000 | 0.34% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 180,000 | $750,000 | 0.20% |
| Penn Capital Management Company, LLC | 543,715 | $2,267,000 | 0.16% |
| HighTower Advisors, LLC | 2,355,942 | $9,826,000 | 0.08% |
| Granite Investment Partners, LLC | 215,760 | $900,000 | 0.06% |
| WRAPMANAGER INC | 39,547 | $165,000 | 0.05% |
| Alyeska Investment Group, L.P. | 1,563,881 | $6,521,000 | 0.05% |